AMD is overexpressed in temozolomide-resistant glioma samples, and AMD knockdown augments the effects mediated by temozolomide on the Akt (protein kinase B), extracellular signal-regulated kinases (ERKs) 1/2, and Bax/Bcl-2 signaling pathways [16]. This evidence concerns the gene BCL2 and central nervous system cancer.